Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19729669.
- Also identified by DOI 10.1164/rccm.200812-1845PP.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The natural history of cystic fibrosis lung disease is one of chronic progression with intermittent episodes of acute worsening of symptoms frequently called acute pulmonary exacerbations These exacerbations typically warrant medical intervention. It is important that appropriate therapies are recommended on the basis of available evidence of efficacy and safety. The Cystic Fibrosis Foundation therefore established a committee to define the key questions related to pulmonary exacerbations, review the clinical evidence using an evidence-based methodology, and provide recommendations to clinicians. It is hoped that these guidelines will be helpful to clinicians in the treatment of individuals with cystic fibrosis.
Medical subject headings
- Adrenal Cortex Hormones
- Anti-Bacterial Agents
- Cystic Fibrosis
- Respiratory Therapy